Aptamer Group Plc (GB:APTA)
LSE:APTA
Want to see GB:APTA full AI Analyst Report?
APTA Stock Chart & Stats
0.80 p
-0.01 p(-2.86%)
At close: 4:00 PM EST
0.80 p
-0.01 p(-2.86%)
Day’s Range― - ―
52-Week Range0.23 p - 1.57 p
Previous CloseN/A
Volume3.91M
Average Volume (3M)15.29M
Market Cap
£18.29M
Enterprise Value17.10M
Total Cash (Recent Filing)£1.53M
Total Debt (Recent Filing)£333.00K
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Oct 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding2,927,061,800
10 Day Avg. Volume14,821,052
30 Day Avg. Volume15,285,032
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)5.32
Price to Sales (P/S)6.11
P/FCF Ratio-3.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved LeverageImproved debt-to-equity indicates the company has reduced leverage pressure, increasing financial flexibility. Over 2-6 months this can lower refinancing risk, reduce interest burden, and buy time for R&D and commercialization efforts without immediate insolvency pressure.
Proprietary Aptamer Platform And Diversified End-marketsA proprietary aptamer discovery and product platform is a durable competitive asset: it supports recurring services revenue, product licensing or assays, and addresses diagnostics, therapeutics and bioprocessing markets. This multi-end-market exposure helps long-run revenue opportunities.
Lean Specialist TeamA small, specialized workforce implies lower fixed overhead and tighter R&D focus. Over months this can preserve cash runway, enable rapid iteration on platform projects, and maintain operational agility while management prioritises commercialization paths.
Bears Say
Severe Revenue DeclineA near-total revenue collapse is a structural red flag: it erodes scale, damages customer relationships, and reduces market credibility. Over the medium term this undermines the firm's ability to fund R&D, retain staff, and execute commercialization strategies without external capital.
Negative Operating And Free Cash FlowPersistent negative operating and free cash flows create ongoing funding needs. Over several months this forces reliance on financing or asset sales, constrains investment in product development and regulatory work, and increases dilution or leverage risk for shareholders.
Persistent Losses And Weak MarginsSustained negative margins and losses reduce retained capital and limit reinvestment capacity. Structurally weak profitability makes it hard to scale commercial operations, attract partners, or secure favorable financing, prolonging dependence on external funding.
Aptamer Group Plc News
APTA FAQ
What was Aptamer Group Plc’s price range in the past 12 months?
Aptamer Group Plc lowest share price was 0.23 p and its highest was 1.57 p in the past 12 months.
What is Aptamer Group Plc’s market cap?
Aptamer Group Plc’s market cap is £18.29M.
When is Aptamer Group Plc’s upcoming earnings report date?
Aptamer Group Plc’s upcoming earnings report date is Oct 20, 2026 which is in 184 days.
How were Aptamer Group Plc’s earnings last quarter?
Aptamer Group Plc released its earnings results on Mar 25, 2026. The company reported 0 p earnings per share for the quarter, the consensus estimate of N/A by 0 p.
Is Aptamer Group Plc overvalued?
According to Wall Street analysts Aptamer Group Plc’s price is currently Overvalued.
Does Aptamer Group Plc pay dividends?
Aptamer Group Plc does not currently pay dividends.
What is Aptamer Group Plc’s EPS estimate?
Aptamer Group Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aptamer Group Plc have?
Aptamer Group Plc has 2,927,061,800 shares outstanding.
What happened to Aptamer Group Plc’s price movement after its last earnings report?
Aptamer Group Plc reported an EPS of 0 p in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -3.846%.
Which hedge fund is a major shareholder of Aptamer Group Plc?
Currently, no hedge funds are holding shares in GB:APTA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aptamer Group Plc
Aptamer Group plc provides binders for research, diagnostics, and therapeutics in the United Kingdom and internationally. The company's binders engineered to address issues which founds with molecules, such as antibodies; and offers solutions to bioprocessing, diagnostic, and pharmaceutical scientists. It serves pharma companies, diagnostic development companies, and research institutes. The company was incorporated in 2014 and is based in York, the United Kingdom.
Technical Analysis
Avacta Group plc
―
Bioventix
―
Oxford BioDynamics
―
Fusion Antibodies Plc
―
Arecor Therapeutics PLC
―
Options Prices
Currently, No data available
---